AURXOTCSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Nuo Therapeutics, Inc.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 14, 2026
$1.26−0.04 (-3.08%)
Close on Oct 19, 2026
- Market cap
- $60.99M
- P/E (TTM)
- –
- Dividend yield
- –
SEC filings
40 of Nuo Therapeutics's most recent filings on SEC EDGAR
| Document | Form | Period | Filed | Source |
|---|---|---|---|---|
| Current report | 8-K | Sep 30, 2026 | Oct 6, 2026 | SEC EDGAR |
| Current report | 8-K | Aug 17, 2026 | Aug 17, 2026 | SEC EDGAR |
| Quarterly report | 10-Q | Jun 30, 2026 | Aug 14, 2026 | SEC EDGAR |
| Current report | 8-K | May 29, 2026 | Jun 3, 2026 | SEC EDGAR |
| Current report | 8-K | May 14, 2026 | May 14, 2026 | SEC EDGAR |
| Quarterly report | 10-Q | Mar 31, 2026 | May 14, 2026 | SEC EDGAR |
| Annual report | 10-K | Dec 31, 2025 | Mar 30, 2026 | SEC EDGAR |
| Current report | 8-K | Jan 21, 2026 | Jan 26, 2026 | SEC EDGAR |
| Current report | 8-K | Dec 16, 2025 | Dec 17, 2025 | SEC EDGAR |
| Quarterly report | 10-Q | Sep 30, 2025 | Oct 30, 2025 | SEC EDGAR |
| Proxy statement | DEF 14A | Dec 16, 2025 | Oct 30, 2025 | SEC EDGAR |
| Current report | 8-K | Oct 7, 2025 | Oct 10, 2025 | SEC EDGAR |
| Quarterly report | 10-Q | Jun 30, 2025 | Jul 31, 2025 | SEC EDGAR |
| Current report | 8-K | May 14, 2025 | May 15, 2025 | SEC EDGAR |
| Quarterly report | 10-Q | Mar 31, 2025 | Apr 30, 2025 | SEC EDGAR |
| Annual report | 10-K | Dec 31, 2024 | Apr 1, 2025 | SEC EDGAR |
| Quarterly report | 10-Q | Sep 30, 2024 | Nov 12, 2024 | SEC EDGAR |
| Current report | 8-K | Sep 18, 2024 | Sep 19, 2024 | SEC EDGAR |
| Quarterly report | 10-Q | Jun 30, 2024 | Aug 12, 2024 | SEC EDGAR |
| Current report | 8-K | Jun 27, 2024 | Jun 27, 2024 | SEC EDGAR |
| Current report | 8-K | Jun 7, 2024 | Jun 11, 2024 | SEC EDGAR |
| Current report | 8-K | May 17, 2024 | May 21, 2024 | SEC EDGAR |
| Quarterly report | 10-Q | Mar 31, 2024 | May 15, 2024 | SEC EDGAR |
| Annual report | 10-K | Dec 31, 2023 | Apr 19, 2024 | SEC EDGAR |
| Current report | 8-K | Apr 16, 2024 | Apr 16, 2024 | SEC EDGAR |
| Current report | 8-K | Dec 18, 2023 | Dec 20, 2023 | SEC EDGAR |
| Quarterly report | 10-Q | Sep 30, 2023 | Nov 20, 2023 | SEC EDGAR |
| Quarterly report | 10-Q | Jun 30, 2023 | Aug 14, 2023 | SEC EDGAR |
| Current report | 8-K | Aug 1, 2023 | Aug 3, 2023 | SEC EDGAR |
| Quarterly report | 10-Q | Mar 31, 2023 | May 15, 2023 | SEC EDGAR |
| Annual report, amended | 10-K/A | Dec 31, 2022 | Apr 18, 2023 | SEC EDGAR |
| Annual report | 10-K | Dec 31, 2022 | Apr 17, 2023 | SEC EDGAR |
| Current report | 8-K | Dec 2, 2022 | Dec 5, 2022 | SEC EDGAR |
| Quarterly report | 10-Q | Sep 30, 2022 | Nov 4, 2022 | SEC EDGAR |
| Quarterly report | 10-Q | Sep 30, 2021 | Nov 4, 2022 | SEC EDGAR |
| Proxy statement | DEF 14A | Dec 2, 2022 | Oct 20, 2022 | SEC EDGAR |
| Current report | 8-K | Sep 29, 2022 | Sep 30, 2022 | SEC EDGAR |
| Current report | 8-K | Aug 24, 2022 | Aug 30, 2022 | SEC EDGAR |
| Quarterly report, amended | 10-Q/A | Jun 30, 2022 | Aug 10, 2022 | SEC EDGAR |
| Quarterly report | 10-Q | Jun 30, 2022 | Aug 8, 2022 | SEC EDGAR |